Cahill Represents Initial Purchasers in a €1.45 Billion Notes Offering for IQVIA Inc.
Date: 03/03/21
Cahill represented the initial purchasers in connection with a Rule 144A offering of €550,000,000 aggregate principal amount of 1.750% senior notes due 2026 and a €900,000,000 aggregate principal amount of 2.250% senior notes due 2029 by IQVIA Inc. Proceeds from the offerings were used to refinance existing indebtedness. IQVIA, formerly Quintiles and IMS Health, Inc., is a multinational company serving the combined industries of health information technology and clinical research.